In Mergers and Acquisitions

Effective April 12, 2023, Dr. Rushing will lead innovative research efforts for Okur-Chung Neurodevelopmental Syndrome, an ultra-rare genetic condition.

SAN FRANCISCO, CALIFORNIA, UNITED STATES, April 2, 2023 /⁨EINPresswire.com⁩/ — In an exciting …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.

Start typing and press Enter to search